Serum type III procollagen, procollagen V, Tumor necrosis factor-α, interleukin-6 in liver cirrhosis after antiviral treatment
Serum PCⅢ, procollagen V TNF-α, IL-6 in cirrhosis
Abstract
Objective: To look into the therapeutic impact of entecavir in combination with reduced glutathione on serum type III procollagen (PCⅢ), plasma procollagen V (IVC),Tumor necrosis factor-α, interleukin-6 in the treatment of hepatitis B complicated with alcoholic liver cirrhosis and the impact on nutritional status.
Methods: The study included 92 patients with alcoholic liver cirrhosis complicating hepatitis B who were treated in our hospital between April 2022 and January 2024. The patients were randomized into two groups using a random number table method: group A, which included 46 patients, and group B, which included 46 patients who were in the experimental group. Patients in group A received treatment with 0.5 mg of entecavir per day, whereas those in group B received 0.5 mg of entecavir per day with 0.3 g of reduced glutathione 1-2 times per day. The treatment was continuous for 2 months.The BMI, TSF, AMC, PA, HB, and ALB were compared between the two groups, as were the clinical treatment outcomes for the two patient groups. The incidence of malnutrition was evaluated using a fully automatic biochemical analyzer, and the incidence of malnutrition was evaluated using SGA nutritional risk screening; The expression levels of inflammatory factors were detected by ELISA before and after treatment in the two groups. Liver function indicators were detected by immunoradiology to detect liver fibrosis indicators; A comparison was made between the two groups' incidence of adverse responses.
Result: Group B's overall effective rate was 97.82%, higher than that of group A (76.08%); The degree of malnutrition decreased after therapy compared to before, and group B fared better than group A, the expression levels of BMI, TSF, AMC, PA, HB, ALB, TNF-α, CRP, IL-6, TBIL, AST, ALT, HA, PCⅢ and IVC in both groups were decreased than group A after treatment, and these in the group B were reduced than group A .
Conclusion: Entecavir combined with reduced glutathione in the treatment of hepatitis B complicated with alcoholic liver cirrhosis can improve liver function, and the nutritional status of patients, reduce inflammatory indicators, and have high safety.
References
Chen, H., Fu J.J., Li, L., Wang X., Pan, X.C., 2024. Risk factors of low‐level viremia in chronic hepatitis B patients receiving Entecavir monotherapy: a retrospective cohort study. J. gastroenterol. hepatol., 39(1): 180-184. https://doi.org/10.1111/jgh.16357
Chen, H., Mruk, D.D., Lee, W.M., and Cheng, C.Y., 2017. Regulation of spermatogenesis by a local functional axis in the testis: role of the basement membrane-derived noncollagenous 1 domain peptide. FASEB J., 31(8): 3587-3607. https://doi.org/10.1096/fj.201700052R
Chon, H.Y., Lee, H.A., Park, S.Y., See, Y.S., Kim, S.G., Lee, C.H., Lee, T.H., Ahn, S.H., Wong, V.W., Yip, T.C., Liang, L.Y., Kim, I.H., Wong, G.L., and Kim, S.U., 2023. CAGE‐B and SAGE‐B models better predict the hepatitis B virus-related hepatocellular carcinoma after 5-year entecavir treatment than PAGE‐B. J. Dig. Dis., 24(2): 113-121. https://doi.org/10.1111/1751-2980.13172
Ebrahimi, F., Zavareh, S. and Nasiri, M., 2024. The combination of estradiol and n-acetylcysteine reduces ischemia-reperfusion injuries of mice autografted ovarian tissue. Biopreserv. Biobank., 22 (1): 29-39. https://doi.org/10.1089/bio.2022.0184
Ekstedt, M., Franzén, L.E., Mathiesen, U.L., Holmqvist, M., Bodemar, G. and Kechagias, S., 2007. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J. Hepatol., 47(1): 135-41. https://doi.org/10.1016/j.jhep.2007.02.013
Hong, Y., Yan, H., Wurichayihu and Zhang, G., 2021. The effects of comprehensive nursing interventions on the negative emotions, quality of life, and nursing satisfaction in intracerebral hemorrhage patients. Am. J. Transl. Res., 13(5): 4860-4867.
Hyun, J., Han, J., Lee, C., Yoon, M. and Jung, Y., 2021. Pathophysiological aspects of alcohol metabolism in the liver. Int. J. Mol. Sci., 22(11):5717. https://doi.org/10.3390/ijms22115717
Isenberg, S.R., 2024. Continuity of care & end-of-life outcomes for people with kidney failure on dialysis: a population-based study (GP114). J. Pain Symptom Manage., 67(5): e815-e816. https://doi.org/10.1016/j.jpainsymman.2024.02.509
Jang, T.Y., 2023. Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues. Aliment. Pharmacol. The., 57(5): 587-588. https://doi.org/10.1111/apt.17329
Kalaycı, B.N. and Balta, L., 2022. Evaluation of the serum C‐reactive protein-albumin ratio and?its relationship with disease severity IN alopecia areata: a prospective case-control study.Journal of cosmetic dermatology., 21(12): 7194-7199. https://doi.org/10.1111/jocd.15460
Karsdal, M.A., Daniels, S.J., Holm Nielsen, S., Bager, C., Rasmussen, D.G.K., Loomba, R., Surabattula, R., Villesen, I.F., Luo, Y., Shevell, D., Gudmann, N.S., Nielsen, M.J., George, J., Christian, R., Leeming, D.J. and Schuppan, D., 2020. Collagen biology and non-invasive biomarkers of liver fibrosis. Liver Int., 40(4): 736-750. https://doi.org/10.1111/liv.14390
Li, Y.G., Yu, Z.J., Li, A. and Ren, Z.G., 2022. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: molecular mechanisms and therapeutic inventions. World J. Gastroenterol., 28(28): 3555-3572. https://doi.org/10.3748/wjg.v28.i28.3555
Liberal, R. and Grant, C.R., 2016. Cirrhosis and autoimmune liver disease: Current understanding. World J. Hepatol., 8(28): 1157-1168. https://doi.org/10.4254/wjh.v8.i28.1157
Ma, M., Liu, Y., Liu, F., Li, Z., Cheng, Q., Liu, Z., Yang, R. and Yu C., 2022. Relationship between prognostic nutrition index and New York heart association classification in patients with coronary heart disease: a RCSCD-TCM study. J. Inflamm. Res., 15: 4303-4314. https://doi.org/10.2147/JIR.S371045
Minnie, S.A., Waltner, O.G., Zhang, P., Takahashi, S., Nemychenkov, N.S., Ensbey, K.S., Schmidt, C.R., Legg, S.R.W., Comstock, M., Boiko, J.R., Nelson, E., Bhise, S.S., Wilkens, A.B., Koyama, M., Dhodapkar, M.V., Chesi, M., Riddell, S.R., Green, D.J., Spencer, A., Furlan, S.N. and Hill, G.R., 2024. TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies. Sci. Immunol., 9(94): eadg1094. https://doi.org/10.1126/sciimmunol.adg1094
Pang, Q., Zhang, J.Y., Xu, X.S., Song, S.D., Qu, K., Chen, W., Zhou, Y.Y., Miao, R.C., Liu, S.S., Dong, Y.F. and Liu, C., 2015. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J. Gastroenterol., 21(18): 5607-21. https://doi.org/10.3748/wjg.v21.i18.5607
Rinninella, E., Cintoni, M., Raoul, P., Pozzo, C., Strippoli, A., Bria, E., Tortora, G., Gasbarrini, A. and Mele, M.C., 2020. Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials. Clin. Nutr. ESPEN., 38: 28-42. https://doi.org/10.1016/j.clnesp.2020.05.007
Sahu, P., Kaushik, K.K. and Nath, S.K., 2022. Effect of Lindane (δ-isomer) on Serum cholesterol and Liver enzyme markers in mice (Mus musculus). Res. J. Pharm. Technol., 15(12): 5721-5723. https://doi.org/10.52711/0974-360X.2022.00964
Seitz, H.K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G. and Tsukamoto H. 2018. Alcoholic liver disease. Nat. Rev. Dis. Primers., 4(1): 16. https://doi.org/10.1038/s41572-018-0014-7
Szwiega, S., Xu, L., Rafii, M., Pencharz, P.B., Kong, D., Tomlinson, C., Elango, R. and Courtney-Martin, G., 2024. Protein intake affects erythrocyte glutathione synthesis in young healthy adults in a repeated-measures trial. Am. J. Clin. Nutr., 119(2): 371-383. https://doi.org/10.1016/j.ajcnut.2023.11.008
Wang, Z.C., Yang, S., Huang, J.J., Chen, S.L., Li, Q.Q. and Li, Y., 2014. Effect of Rougan Huaqian granules combined with human mesenchymal stem cell transplantation on liver fibrosis in cirrhosis rats. Asian. Pac. J. Trop. Med., 7(7): 576-81. https://doi.org/10.1016/S1995-7645(14)60097-3
Wu, G., He, H., Li, H. and Chen, W., 2014. [Clinical effect of combination therapy with Fufang Biejia Ruangan tablet and entecavir in patients with hepatitis B virus-related cirrhosis]. Zhonghua Gan Zang Bing Za Zhi., 22(8): 604-8. https://doi.org/10.3760/cma.j.issn.1007-3418.2014.08.011
Yang, Q., 2023. Clinical efficacy and incidence of adverse reactions of entecavir combined with long-acting interferon in treating hepatitis B. J. Clin. Nurs. Res., 007(006): 41-46. https://doi.org/10.26689/JCNR.V7I6.5632
Zhou, Y., Huang, J., Si Z., Zhou, Q., and Li, L., 2023. Pathogenic factors of cognitive dysfunction after liver transplantation: an observational study. Eur. J. Gastroenterol. Hepatol., 35(6): 668-673. https://doi.org/10.1097/MEG.0000000000002551
Copyright (c) 2025 Wei Li
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.